AUL
ALAB icon

AlphaGrep UK Ltd’s Astera Labs ALAB Stock Holding History

AlphaGrep UK Ltd’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$339K Buy
+3,091
New +$440K 0.1% 452

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

AlphaGrep UK Ltd's ALAB Position: Q1 2026 in Review

AlphaGrep UK Ltd opened a new position in Astera Labs (ALAB) in Q1 2026: 3,091 shares worth $339K. The stake represents 0.1% of the portfolio and ranks #452 among its holdings.

707 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • AlphaGrep UK Ltd held 3,091 shares of Astera Labs worth $339K as of Q1 2026.
  • Astera Labs was a new AlphaGrep UK Ltd position in Q1 2026.
  • Astera Labs made up 0.1% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #452 holding.
  • 707 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.